Ajanta Pharma Limited has informed the Exchange about Schedule of Participation in Investor Conference

Ajanta Pharma Limited has informed the Exchange about Transcript

Ajanta Pharma Limited has informed the Exchange about public Announcement - Buyback of Shares

Ajanta Pharma Limited has informed the Exchange regarding 'Filing of copy of Board Resolution pursuant to the provisions of the SEBI (Buy-Back of Securities) Regulation, 2018 ( Buyback Regulations ) '.

Ajanta Pharma Limited has informed the Exchange about Copy of Newspaper Publication

AJANTA PHARMA LIMITED has informed the Exchange regarding Outcome of Board Meeting held on 02-May-2024 for Buy-back

Ajanta Pharma Limited has informed the Exchange regarding 'Correction Of Error In The Intimation under Regulation 30 of SEBI (LODR) for change in Cost Auditor'.

Ajanta Pharma Limited has informed the Exchange about Link of Recording

Ajanta Pharma Limited has informed the Exchange regarding Appointment of Mr David Rasquinha as Non- Executive Independent Director of the company w.e.f. May 02, 2024.

Ajanta Pharma Limited has informed the Exchange regarding Appointment of Mr Rajesh Dalal as Non- Executive Independent Director of the company w.e.f. May 02, 2024.

Ajanta Pharma Limited has informed the Exchange regarding Appointment of Mrs Medha Joshi as Non- Executive Independent Director of the company w.e.f. May 02, 2024.

Ajanta Pharma Limited has informed the Exchange regarding Appointment of Mrs Simi Thapar as Non- Executive Independent Director of the company w.e.f. May 02, 2024.

AJANTA PHARMA LIMITED has informed the Exchange about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent

Ajanta Pharma Limited has informed the Exchange regarding Allotment of Shares.

Ajanta Pharma Limited has submitted to the Exchange, the financial results for the period ended March 31, 2024.

Ajanta Pharma Limited has informed the Exchange regarding Outcome of Board Meeting held on May 02, 2024.

Ajanta Pharma Limited has informed the Exchange that Record date for the purpose of Buyback is 30-May-2024.

Ajanta Pharma Limited has informed the Exchange regarding 'We hereby inform that at the Board meeting held on Thursday, 2nd May 2024, Board has inter-alia approved the following: 1. 1. Appointment of M/s. RA & Co., Cost Accountants (Firm Registration No:

AJANTA PHARMA LIMITED has informed the Exchange about Board Meeting to be held on 02-May-2024 to consider Buyback.

Ajanta Pharma Limited has informed the Exchange about Schedule of meet